Artemis Medicare Services Limited has informed the Exchange about Credit Rating
ARTEMISMED · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
CARE Ratings has reaffirmed the credit ratings of Artemis Medicare Services Limited following a review based on FY25 audited performance. Long-term bank facilities of ₹427.90 crore retain the 'CARE A; Stable' rating, while long-term/short-term bank facilities of ₹45 crore retain 'CARE A; Stable / CARE A2+'. Notably, the rated long-term facility amount was enhanced from ₹378.21 crore to ₹427.90 crore, including a new proposed facility of ₹80 crore spread across lenders like Axis, HDFC, ICICI, and IDFC First Bank. The reaffirmation indicates CARE's continued comfort with the company's credit profile, while the facility enhancement suggests fresh borrowing capacity being arranged.
The reaffirmed investment-grade rating (CARE A) signals steady financial health and should be neutral to mildly positive for the stock, as it confirms Artemis's ability to service debt. The increase in rated facility size points to upcoming expansion or capex funding, which could support growth but also raises the company's overall debt load.